Respiratory Distress Syndrome Market Analysis and Forecast 2018-2026 | ONY Biotech Inc., AbbVie Inc. Dey Laboratories Inc, Chiesi Farmaceutici, S.p.A.
Respiratory distress syndrome is a lung disorder of neonates caused by a deficiency of surfactants. It affects premature infants with symptoms of collapsed lungs and breathing difficulty. Other symptoms include nasal flaring, use of accessory muscles and grunting respirations. Respiratory distress syndrome is a rare disorder and it affects only a few percent’s of the population. The risk of respiratory distress syndrome increases with prematurity of the infant and it is genetic in origin. Treatment of respiratory distress syndrome mainly includes positive end-expiratory pressure by the physical or mechanical assistance of breathing. Other treatments are supportive and symptomatic. FDA approved Exosurf Neonatal, Survanta, Surfactant TA, Human Surf and Dey Lab’s lung surfactants respectively. Exosurf Neonatal is the first FDA approved synthetic surfactant for the treatment of infant respiratory distress syndrome. It was manufactured by Burroughs Wellcome. Abbott is the second company to get FDA approval for Survanta, which is derived from bovine tissues. Other surfactants include Curosurf Intratracheal Suspension was approved by regulatory authorities for the treatment of respiratory distress syndrome.
Get Sample Copy of this report @ https://www.marketresearchreports.biz/sample/sample/12560
Respiratory Distress Syndrome Market: Drivers and Restraints
According to the National Organization of Rare Diseases, respiratory distress syndrome affects more than 20% of the prematurely born infants with a mortality rate of 10%. It affects both male and female population in an equal proportion. Raising prevalence of respiratory distress syndrome along with high mortality rate boosted the growth the market. Further, rapid improvements in the field of healthcare give opportunities for raising awareness about respiratory distress syndrome. Along with these, regulatory authorities provide the drug with orphan drug status. Orphan drugs have high price elasticity and it offers manufacturers with high-profit margins than other drugs. With these, Orphan drugs also get financial assistance like tax waivers from regulatory authorities. Apart from these, non-profit organizations are promoting research & development around respiratory distress syndrome in joint scientific research between the public sector and the private sector. In association with the non-profit organization, state governments provide special incentives to the manufacturer to develop respiratory distress syndrome drugs. Public-private partnerships are encouraging pharmaceutical companies to develop new orphan drugs for Respiratory Distress Syndrome. All of these factors act as potential drivers for the growth of the respiratory distress syndrome market.
Due to lack of awareness regarding the diseases, the growth of respiratory distress syndrome market was slightly affected.
Respiratory Distress Syndrome Market: Segmentation
Segmentation based on End User
Respiratory Distress Syndrome Market: Market Overview
Global Respiratory Distress Syndrome market has witnessed a robust growth due to increasing demand for effective treatment methods. Manufacturers are majorly concentrated on the development of novel medicines to cure the respiratory distress syndrome. Presently, non-profit organizations along with legislative bodies are taking part in raising awareness in the general population. Respiratory distress syndrome has the presence of limited manufacturers and it offers huge opportunities to innovators due to highly unmet needs. The future of respiratory distress syndrome market anticipated with double growth rate during forecasting period.
Respiratory Distress Syndrome Market: Region-wise Overview
Global Respiratory Distress Syndrome market is segmented into the following regions - North America, Latin America, Western Europe, Eastern Europe, Asia Pacific and the Middle East & Africa. North America is dominant in the global respiratory distress syndrome market mainly due to the increased mortality rate of respiratory distress syndrome. In North America, particularly the USA is dominating due to high awareness of respiratory distress syndrome. Europe is a second leading player in global respiratory distress syndrome due to well-established healthcare systems. Along with this, both North America and Europe region legislations offer reimbursement for the treatment of respiratory distress syndrome. The Asia Pacific Is anticipated to the third most leading player in global respiratory distress syndrome due to the high prevalence of respiratory distress syndrome and prematurity birth of infants. However, Latin America and Middle East & Africa regions account for a small share in the global market due to lack of awareness regarding respiratory distress syndrome and it is expected to increase during the forecast period.
Request For TOC Report @ https://www.marketresearchreports.biz/sample/toc/12560
Respiratory Distress Syndrome Market: Key Participants
The key participants in Respiratory Distress Syndrome Market are ONY Biotech Inc., AbbVie Inc. Dey Laboratories Inc, Chiesi Farmaceutici, S.p.A., and others. The companies are mainly focusing on collaboration and partnership to keep up the pace of the competition and to develop new products.
The report covers an exhaustive analysis on:
Historical Actual Market Size, 2013 – 2017
Market Size & Forecast, 2018 to 2026
Supply & Demand Value Chain
Market Current Trends/Issues/Challenges
Competition & Companies involved
Aircraft Refurbishing Market Drivers and Restraints
Regional analysis for Market includes
Asia Pacific & Japan
Middle East & Africa
Shifting Industry dynamics
In-depth market segmentation
Historical, current and projected industry size, recent industry trends
Key Competition landscape
Strategies for key players and product offerings
Potential and niche segments/regions exhibiting promising growth
A neutral perspective towards market performance
Request To PRE BOOK This Premium Report From Here @ https://www.marketresearchreports.biz/checkout?rep_id=12560&licType=S
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
90 Sate Street, Suite 700
Albany, NY 12207
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Respiratory Distress Syndrome Market Analysis and Forecast 2018-2026 | ONY Biotech Inc., AbbVie Inc. Dey Laboratories Inc, Chiesi Farmaceutici, S.p.A. here
News-ID: 1428967 • Views: 462
More Releases for America
Latin America Colour Cosmetics Market
The colour cosmetics market in Latin America managed to keep its head above water over 2011-2016. The category recorded a CAGR of 1.7% despite a decline in value occurring towards the end of the period, Chile and Argentina offsetting the impact of economic crisis in Brazil and Venezuela. Direct selling still holds strong as the core channel for colour cosmetics purchases in the region but retail infrastructure is rapidly improving
South America Aviation Market
The South American aviation market was affected adversely by the financial crisis, which had originated in the United States and the sales were impacted adversely by the same, but the market has recovered, since. Furthermore, the good performance of regional jets sold by Embraer were termed profitable by users and could certainly turn the tide as aircraft orders from other airlines continue to increase. Rising income levels in the continent
Agrochemicals Market in North America
ReportsWorldwide has announced the addition of a new report title North America: Agrochemicals: Market Intelligence (2016-2021) to its growing collection of premium market research reports. The report “North America: Agrochemicals: Market Intelligence (2016-2021)” provides market intelligence on the different market segments, based on type, active ingredient, formulation, crop, and pest. Market size and forecast (2016-2021) has been provided in terms of both, value (000 USD) and volume (000 KG) in the
Make America Great Again
Help us open our Veterans' Home We don't know them all, but we owe them all... Lake Ariel, PA: FCPCF Inc. and National Auto Raffle invites you to enter the online Charity Auto & 50/50 Raffles (www.nationalautoraffle.com) and help us raise funds to open the doors of veterans' housing facility and provide housing to the homeless Veterans and their families in need. Every 1 in 4 homeless is a Veteran and its time
Latin America Oil & Gas Potential
Produced by The CWC Group, Latin American Oil and Gas Conference takes place on 25 – 27 October 2011, Mandarin Oriental Hotel, Miami, U.S.A. Organisers confirmed that the strategic conference will feature advanced insights from important organisations in the region alongside NOC’s showcases from Brazil, Mexico, Colombia, Trinidad & Tobago, Venezuela, Uruguay and Bolivia. Content centres on the development of the Latin America’s resources, the impact of shale
Mafi Designs America
Austrian Natural Wood Floor manufacturer establishes themselves in the high end New York Lifestyle market. “Successfully building a luxury Brand in the US is very important to our world wide marketing efforts,“ proclaims a happy Philippe S. Pezet, Partner Mafi USA, Inc & Export/Marketing Manger for the manufacturing company Mafi Holzverarbeitung from Austria. The Mafi brand name is recognized by leading architects and decorators in the Big Apple as being the